Amyl Therapeutics (SRL)
Active
VAT
BE 0758.775.372
Address
Boulevard de Patience et Beaujonc 3
4000
Liège
Established
26-11-2020
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Amyl Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Amyl Therapeutics
2023
|
2022
|
2021
|
|||
|---|---|---|---|---|---|
| Profit/Loss | -€1,709,641 | -21% |
-€1,415,300 | -42% |
-€999,692 |
| Equity | €7,999,014 | 29% |
€6,208,656 | -19% |
€7,623,956 |
| Gross margin | -€674,399 | 20% |
-€840,592 | 4% |
-€875,058 |
| Employees | 4,6 FTE | 100% |
2,3 FTE | 229% |
0,7 FTE |
Publications in the Belgian Official Journal for Amyl Therapeutics
Frequently asked questions
What is the VAT number of Amyl Therapeutics?
The VAT number of Amyl Therapeutics is BE0758775372.
When was Amyl Therapeutics founded?
Amyl Therapeutics was founded on 26-11-2020.
What is the address of Amyl Therapeutics?
The current registered office of Amyl Therapeutics is located at Boulevard de Patience et Beaujonc 3, 4000 Liège.
When was the last time Amyl Therapeutics filed their annual financial statements?
The most recent financial statements of Amyl Therapeutics were filed on 12-06-2024. You can view them here.
How many employees does Amyl Therapeutics have?
There are 4,6 FTEs working at Amyl Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Amyl Therapeutics?
At the time of its most recent financial statements, Amyl Therapeutics did not publish any turnover figures. Amyl Therapeutics reported a gross margin of -€674,398.88.
